Leuprorelin acetate
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (National)
256.7K
NHS Cost
£47.5M
Practices
5,539
Avg per Practice
46
Overview
Leuprorelin acetate is prescribed by 5,539 GP practices across England. In the last 12 months, 256,689 items were prescribed at a total cost of £47,502,899 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.
Monthly Prescribing Trend
Jun 2026
15,799
Jun 2026
15,185
Jun 2026
16,433
Jun 2026
15,700
Jun 2026
15,446
Jun 2026
16,511
Jun 2026
14,983
Jun 2026
16,178
Jun 2026
17,276
Jun 2026
15,588
Jun 2026
15,788
Jun 2026
16,027
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 11.6K | 161 | 72 | +55.3% ▲ |
| B | 10.3K | 176 | 59 | +27.0% ▲ |
| PE | 8,069 | 79 | 102 | +120.5% ▲ |
| LS | 7,952 | 86 | 93 | +99.8% ▲ |
| PO | 6,920 | 60 | 115 | +149.0% ▲ |
| DE | 6,453 | 77 | 84 | +81.0% ▲ |
| BN | 6,315 | 65 | 97 | +109.9% ▲ |
| GL | 6,099 | 63 | 97 | +109.1% ▲ |
| DN | 5,909 | 77 | 77 | +65.7% ▲ |
| NR | 5,158 | 59 | 87 | +88.8% ▲ |
| SS | 4,921 | 69 | 71 | +54.0% ▲ |
| SN | 4,843 | 44 | 110 | +137.8% ▲ |
| BH | 4,791 | 48 | 100 | +115.6% ▲ |
| NE | 4,513 | 93 | 49 | +4.8% ▲ |
| YO | 4,422 | 43 | 103 | +122.0% ▲ |
| CM | 4,338 | 66 | 66 | +41.9% ▲ |
| TN | 4,319 | 61 | 71 | +52.9% ▲ |
| TS | 4,298 | 65 | 66 | +42.8% ▲ |
| ST | 4,294 | 73 | 59 | +27.0% ▲ |
| DY | 3,869 | 50 | 77 | +67.2% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| MODALITY PARTNERSHIP (AWC) | 741 |
| HOLDERNESS HEALTH | 578 |
| SUTTON COLDFIELD GROUP PRACTICE | 573 |
BNF Classification
- Chapter: Malignant Disease and Immunosuppression
- Section: Sex hormones and hormone antagonists in malignant disease
- Paragraph: Hormone antagonists
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.